EUVIMEDEUVIMED entdecken
Crossref

Variation in Lipid Management for Atherosclerotic Cardiovascular Disease Across US Health Systems

Nishant P Shah iD, Eric D Peterson iD, Peter Shrader, Satoshi Shoji iD, Nikki Freeman iD, Seth S Martin iD, Clint Allred, Soledad Fernandez iD, Alanna M Chamberlain iD, Jonathan Arnold iD, Michael D Shapiro iD, Mark B Effron iD und 10 weitere

Circulation: Population Health and Outcomes · 2026

DOI: 10.1161/circoutcomes.125.012622 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Population Health and Outcomes, 2026. Verfasst von Nishant P Shah und 21 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Duke University School of Medicine, Durham, NC (N.P.S., S.S.). Hauptthemen laut MEDLINE: Atherosclerosis, Cholesterol, LDL, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hypolipidemic Agents. Die Arbeit nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: While health systems have implemented resources to improve lipid management in people with atherosclerotic cardiovascular disease, the population-level effectiveness is unclear. METHODS: Electronic health record data from patients with atherosclerotic cardiovascular disease between January 1, 2021, and December 31, 2023, across 16 US academic health systems were analyzed. Atherosclerotic cardiovascular disease (defined by diagnosis and procedure codes) was established on or before the index date defined as the date of the most recent LDL-C (low-density lipoprotein-cholesterol) or the last day of the study period for those without an LDL-C available. Systems were surveyed to identify lipid management programs (eg, prevention/lipid clinic, electronic health record–based tools, and lipid management algorithms). Sequential multilevel multivariable logistic regression modeling was used to (1) assess the system-level association between an LDL-C

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisCholesterol, LDLHydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic AgentsPractice Patterns, Physicians'HumansFemaleMaleUnited StatesMiddle AgedAgedElectronic Health RecordsCardiovascular Diseases

Stichwörter der Autor:innen

cardiovascular diseasescholesterol, LDLelectronic health recordslipidspopulation health

Substanzen

Cholesterol, LDLHydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic Agents

Autor:innen und Institutionen

  • Division of Cardiology, Duke University School of Medicine, Durham, NC (N.P.S., S.S.).
  • Division of Cardiology, University of Texas Southwestern Medical Center, Dallas (E.D.P., Z.A., A.M.N.).
  • Duke Clinical Research Institute, Durham, NC (P.S., S.S., N.F.).
  • Division of Cardiology, Johns Hopkins School of Medicine, Baltimore, MD (S.S.M.).
  • Department of Population Health, University of Utah, Salt Lake City (C.A.).
  • St Luke's Health Idaho Cardiology Associates, Boise (C.A.).

ORCID-Profile: Nishant P Shah, Eric D Peterson, Satoshi Shoji, Nikki Freeman, Seth S Martin, Soledad Fernandez, Alanna M Chamberlain, Jonathan Arnold, Michael D Shapiro, Mark B Effron, Mahanaz Syed, H Lester Kirchner, Bethany Kalich, Ran Jin, Cezary Wojcik, Ann Marie Navar

Zitieren

APA

Shah, N. P., Peterson, E. D., Shrader, P., Shoji, S., Freeman, N., Martin, S. S., Allred, C., Fernandez, S., Chamberlain, A. M., Arnold, J., Shapiro, M. D., Effron, M. B., Priest, E., Syed, M., Kirchner, H. L., Leja, M., Ahmad, Z., Kalich, B., Jin, R., …, & Navar, A. M. (2026). Variation in Lipid Management for Atherosclerotic Cardiovascular Disease Across US Health Systems. Circulation: Population Health and Outcomes. https://doi.org/10.1161/circoutcomes.125.012622

Vancouver

Shah NP, Peterson ED, Shrader P, Shoji S, Freeman N, Martin SS, et al. Variation in Lipid Management for Atherosclerotic Cardiovascular Disease Across US Health Systems. Circulation: Population Health and Outcomes. 2026. doi:10.1161/circoutcomes.125.012622

BibTeX
@article{Shah2026,
  author = {Shah, Nishant P and Peterson, Eric D and Shrader, Peter and Shoji, Satoshi and Freeman, Nikki and Martin, Seth S and Allred, Clint and Fernandez, Soledad and Chamberlain, Alanna M and Arnold, Jonathan and Shapiro, Michael D and Effron, Mark B and Priest, Elisa and Syed, Mahanaz and Kirchner, H Lester and Leja, Monika and Ahmad, Zahid and Kalich, Bethany and Jin, Ran and Jones, Laney K and Wojcik, Cezary and Navar, Ann Marie},
  title = {Variation in Lipid Management for Atherosclerotic Cardiovascular Disease Across US Health Systems},
  journal = {Circulation: Population Health and Outcomes},
  year = {2026},
  doi = {10.1161/circoutcomes.125.012622}
}
Kostenlos starten →